You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Nav1.7 antibody (ab65167)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Nav1.7 antibody
See all Nav1.7 products (6) ...

Description

Rabbit polyclonal to Nav1.7

Tested applications

ICC/IF, IHC-P, IHC-Fr, WB, IHC-FoFrmore details

Cross reactivity

Reacts with

Mouse, Human

Predicted to work with

Rat

Immunogen

Synthetic peptide derived from N terminal human Nav1.7.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: Whole serum

Purity

Whole antiserum

Clonality

Polyclonal

Isotype

IgG

  • Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167)Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167)Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab65167 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient. It is a tetrodotoxin-sensitive Na(+) channel isoform. Plays a role in pain mechanisms, especially in the development of inflammatory pain.

Tissue specificity

Expressed strongly in dorsal root ganglion, with only minor levels elsewhere in the body, smooth muscle cells, MTC cell line and C-cell carcinoma. Isoform 1 is expressed preferentially in the central and peripheral nervous system. Isoform 2 is expressed preferentially in the dorsal root ganglion.

Involvement in disease

Defects in SCN9A are the cause of primary erythermalgia (PERYTHM) [MIM:133020]. It is an autosomal dominant disease characterized by recurrent episodes of severe pain associated with redness and warmth in the feet or hands.
Defects in SCN9A are the cause of congenital indifference to pain autosomal recessive (CIPAR) [MIM:243000]; also known as channelopathy-associated insensitivity to pain. A disorder characterized by congenital inability to perceive any form of pain, in any part of the body. All other sensory modalities are preserved and the peripheral and central nervous systems are apparently intact. Patients perceive the sensations of touch, warm and cold temperature, proprioception, tickle and pressure, but not painful stimuli. There is no evidence of a motor or sensory neuropathy, either axonal or demyelinating.
Defects in SCN9A are a cause of paroxysmal extreme pain disorder (PEPD) [MIM:167400]; previously known as familial rectal pain (FRP). PEPD is an autosomal dominant paroxysmal disorder of pain and autonomic dysfunction. The distinctive features are paroxysmal episodes of burning pain in the rectal, ocular, and mandibular areas accompanied by autonomic manifestations such as skin flushing.
Defects in SCN9A are a cause of generalized epilepsy with febrile seizures plus type 7 (GEFS+7) [MIM:604233]. GEFS+7 is a rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.
Defects in SCN9A are the cause of familial febrile convulsions type 3B (FEB3B) [MIM:604403]. FEB3B consists of seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy.

Sequence similarities

Belongs to the sodium channel (TC 1.A.1.10) family. Nav1.7/SCN9A subfamily.
Contains 1 IQ domain.

Domain

The sequence contains 4 internal repeats, each with 5 hydrophobic segments (S1,S2,S3,S5,S6) and one positively charged segment (S4). Segments S4 are probably the voltage-sensors and are characterized by a series of positively charged amino acids at every third position.

Post-translational
modifications

Ubiquitinated by NEDD4L; which may promote its endocytosis. Does not seem to be ubiquitinated by NEDD4.

Cellular localization

Membrane. In neurite terminals.

Target information above from: UniProt accessionQ15858 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • ETHA antibody
  • hNE Na antibody
  • hNE-Na antibody
  • hNENa antibody
  • NE NA antibody
  • NE-NA antibody
  • NENA antibody
  • Neuroendocrine sodium channel antibody
  • Peripheral sodium channel 1 antibody
  • PN1 antibody
  • SCN9A antibody
  • SCN9A_HUMAN antibody
  • Sodium channel protein type 9 subunit alpha antibody
  • Sodium channel protein type IX subunit alpha antibody
  • Sodium channel voltage gated type IX alpha antibody
  • Sodium channel voltage gated type IX alpha polypeptide antibody
  • Sodium channel voltage gated type IX alpha subunit antibody
  • sodium channel, voltage-gated, type IX, alpha antibody
  • sodium channel, voltage-gated, type IX, alpha polypeptide antibody
  • sodium channel, voltage-gated, type IX, alpha subunit antibody
  • Voltage gated sodium channel alpha subunit Nav1.7 antibody
  • Voltage gated sodium channel subunit alpha Nav1 antibody
  • voltage-gated sodium channel alpha subunit Nav1.7 antibody
  • Voltage-gated sodium channel subunit alpha Nav1 antibody
  • Voltage-gated sodium channel subunit alpha Nav1.7 antibody
see all

Anti-Nav1.7 antibody images:

  Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167)

Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167)

ab65167 staining Nav1.7 in human sperm cells by Immunocytochemistry/ Immunofluorescence.

Sperm cells were washed, re-suspended in phosphate-buffered saline and smeared onto poly-L-lysine-coated slides. Spermatozoa were then fixed by incubation in cold methanol (-20°C) for 20 minutes. Slides were washed three times for 10 minutes with PBS and incubated with 2% BSA in PBS for 30 minutes to block non-specific sites. Test slides were incubated with ab65167 at a 1/100 dilution. Samples were washed three times in PBS, and incubated for 60 minutes with appropriate FITC-conjugated secondary antibodies. Slides were further washed in PBS, mounted using Vectashield and examined with a Olympus BX-51 fluorescence microscopy using a 100× immersion objective.

Image from Pinto FM et al, Reprod Biol Endocrinol. 2009 Jul 16;7:71, Fig 2.

  Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167)

Immunocytochemistry/ Immunofluorescence - Nav1.7 antibody (ab65167)

ICC/IF image of ab65167 stained PC12 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab65167, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-Nav1.7 antibody (ab65167)

This product has been referenced in:

See 1 publication for this product

Publishing research using ab65167? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"